Sponsor Dossier
Norgine
Sponsor Dossier for Norgine. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ANGUSTA
- Brand: FERACCRU
- Brand: IFINWIL
- Brand: MOVICOL
- Brand: MOVIPREP
- Brand: PEDMARQSI
- Brand: PLENVU
- Brand: XIFAXAN
About
Norgine is an Australian Private Company with ABN 78005022882, registered in NSW. The entity is active and registered for GST from 2000-07-01.
Portfolio
Norgine has 8 brands on the ARTG, of which 7 are indexable and 7 carry a Product Information document. 2 brands are PBS-listed, 3 have a PBAC outcome on record, and 1 has an AusPAR on record. Notable brands include ANGUSTA, FERACCRU, IFINWIL, MOVICOL, MOVIPREP, PEDMARQSI, PLENVU, XIFAXAN.
Therapeutic focus
— Gastroenterology: 3 brands — Oncology: 2 brands — Haematology: 1 brand — Infectious Disease: 1 brand — Reproductive Health: 1 brand
PBS footprint
2 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2025-03-01, across 3 brands with a PBAC outcome on record. The latest AusPAR is 2015-12-01, across 1 brand with an AusPAR on record.